Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10073174 | 0.82 | ALDH1A1 (0.33) | NPSR1MEN1CYP3A4KMT2AALDH1A1 | |
| SCHEMBL10072896 | 0.80 | — | — | |
| SCHEMBL16670401 | 0.80 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL2728634 | 0.78 | CYP2C19 (0.32) | — | |
| SCHEMBL19231488 | 0.77 | — | — | |
| SCHEMBL23366120 | 0.76 | — | — | |
| SCHEMBL18653337 | 0.76 | — | — | |
| SCHEMBL21738681 | 0.76 | — | — | |
| SCHEMBL18087338 | 0.76 | CYP2C19 (0.33) | L3MBTL1 | |
| SCHEMBL17662468 | 0.76 | TSHR (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4377363-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | The University of Manchester (GB) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023006909-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | THE UNIVERSITY OF MANCHESTER (GB) | 2023-02-02 | — | — | WO | disclosed |
| US-20230035986-A1 | NOVEL CROSSLINKED ALGINIC ACID | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2023-02-02 | — | — | US | disclosed |
| US-20210221835-A1 | CARBON-MONOXIDE-RELEASING MOLECULES AND THERAPEUTIC APPLICATIONS THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-07-22 | — | — | US | disclosed |
| US-10751344-B2 | Carbon monoxide-releasing molecules for therapeutic applications and methods for the preparation and use thereof | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2020-08-25 | — | — | US | disclosed |
| US-20190350937-A1 | CARBON MONOXIDE-RELEASING MOLECULES FOR THERAPEUTIC APPLICATIONS AND METHODS FOR THE PREPARATION AND USE THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2019-11-21 | — | — | US | disclosed |
| US-10300069-B2 | Carbon monoxide-releasing molecules for therapeutic applications and methods of making and using thereof | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2019-05-28 | — | — | US | disclosed |
| WO-2018093924-A1 | CARBON MONOXIDE-RELEASING MOLECULES AND THERAPEUTIC APPLICATIONS THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2018-05-24 | — | — | WO | disclosed |
| US-20170128456-A1 | CARBON MONOXIDE-RELEASING MOLECULES FOR THERAPEUTIC APPLICATIONS AND METHODS OF MAKING AND USING THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC, (US) | 2017-05-11 | — | — | US | disclosed |
| US-20170128456-A1 | CARBON MONOXIDE-RELEASING MOLECULES FOR THERAPEUTIC APPLICATIONS AND METHODS OF MAKING AND USING THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC, (US) | 2017-05-11 | — | — | US | disclosed |
| US-9476883-B2 | Cellular recognition conjugates and methods of use for the histological analysis of cancer tissue using MALDI-MS imaging | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2016-10-25 | — | — | US | disclosed |
| US-9476883-B2 | Cellular recognition conjugates and methods of use for the histological analysis of cancer tissue using MALDI-MS imaging | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2016-10-25 | — | — | US | disclosed |
| US-9476883-B2 | Cellular recognition conjugates and methods of use for the histological analysis of cancer tissue using MALDI-MS imaging | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2016-10-25 | — | — | US | disclosed |
| WO-2015191616-A1 | CARBON MONOXIDE-RELEASING MOLECULES FOR THERAPEUTIC APPLICATIONS AND METHODS OF MAKING AND USING THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2015-12-17 | — | — | WO | disclosed |
| US-20140315220-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2014-10-23 | — | — | US | disclosed |
| US-20140315220-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2014-10-23 | — | — | US | disclosed |
| US-20140315220-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2014-10-23 | — | — | US | disclosed |
| EP-2734043-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | Georgia State University Research Foundation, Inc. (US) | 2014-05-28 | — | — | EP | disclosed |
| WO-2013013130-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-01-24 | — | — | WO | disclosed |
| WO-2013013130-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170128456-A1 | CARBON MONOXIDE-RELEASING MOLECULES FOR THERAPEUTIC APPLICATIONS AND METHODS OF MAKING AND USING THEREOF | MB, CYC1, COX15 | NPSR1 874/4885MAPT 3963/4885MEN1 2152/4885 |
| US-20210221835-A1 | CARBON-MONOXIDE-RELEASING MOLECULES AND THERAPEUTIC APPLICATIONS THEREOF | MB, HMOX1, CYC1 | NPSR1 874/4885MAPT 3633/4885MEN1 2719/4885 |
| US-10751344-B2 | Carbon monoxide-releasing molecules for therapeutic applications and methods for the preparation and use thereof | MB, CYC1, HMOX1 | NPSR1 978/4885MAPT 3624/4885MEN1 2461/4885 |
| US-10300069-B2 | Carbon monoxide-releasing molecules for therapeutic applications and methods of making and using thereof | MB, CYC1, COX15 | NPSR1 874/4885MAPT 3963/4885MEN1 2152/4885 |
| US-20190350937-A1 | CARBON MONOXIDE-RELEASING MOLECULES FOR THERAPEUTIC APPLICATIONS AND METHODS FOR THE PREPARATION AND USE THEREOF | MB, CYC1, HMOX1 | NPSR1 978/4885MAPT 3624/4885MEN1 2461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.